PT  - JOURNAL ARTICLE
AU  - Worsley, David R.
AU  - Louise, Jennie
AU  - Bull, Susan P.
TI  - Subthreshold Nanosecond Laser Treatment of Intermediate AMD without Reticular Pseudodrusen: Real-world Three-year Follow-up Study
AID  - 10.1101/2022.05.29.22275655
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.05.29.22275655
4099  - http://medrxiv.org/content/early/2022/11/07/2022.05.29.22275655.short
4100  - http://medrxiv.org/content/early/2022/11/07/2022.05.29.22275655.full
AB  - Purpose Subthreshold nanosecond laser (SNL) has been proposed to reduce the risk of intermediate age-related macular degeneration (iAMD) progressing to late AMD. The phase 3 LEAD Study post-hoc analysis indicates a potentially large benefit from SNL treatment of eyes without reticular pseudodrusen. This real-world study reports the three-year outcomes of SNL treatment of iAMD without RPD.Methods An observational retrospective single-centre cohort study of all patients with iAMD, centre-involving very large soft drusen (≥250 μm diameter) without RPD, treated with SNL and with three-year follow up. The primary outcome measured was progression to late AMD; neovascular AMD (nAMD) or geographic atrophy (GA).Results There were 120 eyes of 64 patients. At baseline, the cohort had a high risk profile; drusen median area, volume and largest diameter were 0.70mm2 (IQR: 0.20 to 1.50), 0.03mm3 (IQR: 0.01 to 0.08) and 835μm (IQR: 446.50 to 1398.50) respectively; hyperreflective foci were present in 56.67%; and hyporeflective drusen cores in 25.83%. Eyes had a mean of 3.03 treatments. By three years, progression to late AMD occurred in 5.83% of eyes, all to GA. Visual acuity was stable or improved in 80% of eyes.Conclusion The three-year progression rate was low compared with published 36-month natural histories of iAMD without RPD. The progression rate was similar to the LEAD study SNL-treated group of iAMD without RPD. This study supports the hypothesis that SNL for iAMD without RPD may reduce progression to late AMD. Further investigation is warranted.Competing Interest StatementThe authors have declared no competing interest.Funding StatementJL's organisation (Adelaide Health Technology Assessment, University of Adelaide) received payment from Nova-Eye Medical for initial statistical analyses; however further analyses and collaboration on the manuscript was subsequently done independently.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The national ethics committees for New Zealand are, by legislation, the Health and Disability Ethics Committees. The Health and Disability Ethics Committees are, by law, the only ethics committees for Hamilton Eye Clinic (the institution where the Study was carried out). The Health and Disability Ethics Committees Office has waived the need for committee review for this study, as it is observational, uses only de-identified data and has no active human participants. I attach the letter from the Health and Disability Ethics Committees Office that states this.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript